1 | abuse | 4,451 |
2 | misuse | 773 |
3 | intoxication | 697 |
4 | overdose | 361 |
5 | abusers | 290 |
6 | maltreatment | 250 |
7 | administration-approved | 93 |
8 | overdoses | 81 |
9 | abusing | 58 |
10 | abuse/dependence | 40 |
11 | abuses | 34 |
12 | use-related | 33 |
13 | abuser | 21 |
14 | misusers | 16 |
15 | waivers | 9 |
16 | abuse/neglect | 7 |
17 | administration-defined | 5 |
18 | consumption-related | 5 |
19 | detralex | 5 |
20 | indomethacine | 5 |
21 | molesters | 5 |
22 | 2,2,6,6-tetramethylpiperidine | 4 |
23 | dependence/harmful | 4 |
24 | dinac | 4 |
25 | p-mediated | 4 |
26 | prolit | 4 |
27 | qinghao | 4 |
28 | reactions/events | 4 |
29 | use/sud | 4 |
30 | administration-recommended | 3 |
31 | behaviour/disability | 3 |
32 | bosch | 3 |
33 | breakage/slippage | 3 |
34 | eric-3 | 3 |
35 | oxeglitazar | 3 |
36 | 3-/4-flouroephedrine | 2 |
37 | abstinents | 2 |
38 | abuse-funded | 2 |
39 | attributability | 2 |
40 | challenge/de-challenge/re-challenge | 2 |
41 | consumption/demand | 2 |
42 | days-at-risk | 2 |
43 | gr.a | 2 |
44 | minders | 2 |
45 | stores/shops | 2 |
46 | torsadogenicity | 2 |
47 | use-as-coping | 2 |
48 | use.there | 2 |
49 | abuse/day | 1 |
50 | abuse/linjuries | 1 |
51 | addiction/alcoholism | 1 |
52 | administation-approved | 1 |
53 | administration- | 1 |
54 | administration-associated | 1 |
55 | administrration-approved | 1 |
56 | admistration | 1 |
57 | age=4.4years | 1 |
58 | apologized | 1 |
59 | approvement | 1 |
60 | carbabanzpyrid | 1 |
61 | class-outcome | 1 |
62 | classes-diuretics | 1 |
63 | consumption≥world | 1 |
64 | cord- | 1 |
65 | cristallinity | 1 |
66 | cross-tolerant | 1 |
67 | dependence-associated | 1 |
68 | dependence/abuse | 1 |
69 | dispensers/sellers | 1 |
70 | doxorubucin | 1 |
71 | drowns | 1 |
72 | gr.b+c | 1 |
73 | hepatobiliar | 1 |
74 | interaction-determined | 1 |
75 | items/patient | 1 |
76 | liprimar | 1 |
77 | maytensine | 1 |
78 | misallocations | 1 |
79 | misuse-oriented | 1 |
80 | neediness | 1 |
81 | offences.biological | 1 |
82 | offending.the | 1 |
83 | opportunities-among | 1 |
84 | orientation/gender | 1 |
85 | p-expressing | 1 |
86 | p-nk-1 | 1 |
87 | p-saporin | 1 |
88 | pentedrone | 1 |
89 | perlapine | 1 |
90 | pre-experiences | 1 |
91 | prime/aggression | 1 |
92 | rdea594 | 1 |
93 | reactions/interactions | 1 |
94 | released/min | 1 |
95 | rule/availability | 1 |
96 | soledum® | 1 |
97 | symptoms/suffering | 1 |
98 | telepsychiatric | 1 |
99 | treatments/placebo | 1 |
100 | uptake/retention | 1 |
101 | urges/use | 1 |
102 | use-driven | 1 |
103 | use.genet | 1 |
104 | use/protected | 1 |
105 | users/abusers | 1 |
106 | usexaud | 1 |
107 | vihar | 1 |
108 | weight-classification | 1 |
109 | welfare- | 1 |
1 | 2,2,6,6-tetramethylpiperidine | 4 |
2 | 3-/4-flouroephedrine | 2 |
3 | abstinents | 2 |
4 | abuse | 4,451 |
5 | abuse-funded | 2 |
6 | abuse/day | 1 |
7 | abuse/dependence | 40 |
8 | abuse/linjuries | 1 |
9 | abuse/neglect | 7 |
10 | abuser | 21 |
11 | abusers | 290 |
12 | abuses | 34 |
13 | abusing | 58 |
14 | addiction/alcoholism | 1 |
15 | administation-approved | 1 |
16 | administration- | 1 |
17 | administration-approved | 93 |
18 | administration-associated | 1 |
19 | administration-defined | 5 |
20 | administration-recommended | 3 |
21 | administrration-approved | 1 |
22 | admistration | 1 |
23 | age=4.4years | 1 |
24 | apologized | 1 |
25 | approvement | 1 |
26 | attributability | 2 |
27 | behaviour/disability | 3 |
28 | bosch | 3 |
29 | breakage/slippage | 3 |
30 | carbabanzpyrid | 1 |
31 | challenge/de-challenge/re-challenge | 2 |
32 | class-outcome | 1 |
33 | classes-diuretics | 1 |
34 | consumption-related | 5 |
35 | consumption/demand | 2 |
36 | consumption≥world | 1 |
37 | cord- | 1 |
38 | cristallinity | 1 |
39 | cross-tolerant | 1 |
40 | days-at-risk | 2 |
41 | dependence-associated | 1 |
42 | dependence/abuse | 1 |
43 | dependence/harmful | 4 |
44 | detralex | 5 |
45 | dinac | 4 |
46 | dispensers/sellers | 1 |
47 | doxorubucin | 1 |
48 | drowns | 1 |
49 | eric-3 | 3 |
50 | gr.a | 2 |
51 | gr.b+c | 1 |
52 | hepatobiliar | 1 |
53 | indomethacine | 5 |
54 | interaction-determined | 1 |
55 | intoxication | 697 |
56 | items/patient | 1 |
57 | liprimar | 1 |
58 | maltreatment | 250 |
59 | maytensine | 1 |
60 | minders | 2 |
61 | misallocations | 1 |
62 | misuse | 773 |
63 | misuse-oriented | 1 |
64 | misusers | 16 |
65 | molesters | 5 |
66 | neediness | 1 |
67 | offences.biological | 1 |
68 | offending.the | 1 |
69 | opportunities-among | 1 |
70 | orientation/gender | 1 |
71 | overdose | 361 |
72 | overdoses | 81 |
73 | oxeglitazar | 3 |
74 | p-expressing | 1 |
75 | p-mediated | 4 |
76 | p-nk-1 | 1 |
77 | p-saporin | 1 |
78 | pentedrone | 1 |
79 | perlapine | 1 |
80 | pre-experiences | 1 |
81 | prime/aggression | 1 |
82 | prolit | 4 |
83 | qinghao | 4 |
84 | rdea594 | 1 |
85 | reactions/events | 4 |
86 | reactions/interactions | 1 |
87 | released/min | 1 |
88 | rule/availability | 1 |
89 | soledum® | 1 |
90 | stores/shops | 2 |
91 | symptoms/suffering | 1 |
92 | telepsychiatric | 1 |
93 | torsadogenicity | 2 |
94 | treatments/placebo | 1 |
95 | uptake/retention | 1 |
96 | urges/use | 1 |
97 | use-as-coping | 2 |
98 | use-driven | 1 |
99 | use-related | 33 |
100 | use.genet | 1 |
101 | use.there | 2 |
102 | use/protected | 1 |
103 | use/sud | 4 |
104 | users/abusers | 1 |
105 | usexaud | 1 |
106 | vihar | 1 |
107 | waivers | 9 |
108 | weight-classification | 1 |
109 | welfare- | 1 |
1 | cord- | 1 |
2 | welfare- | 1 |
3 | administration- | 1 |
4 | p-nk-1 | 1 |
5 | eric-3 | 3 |
6 | rdea594 | 1 |
7 | gr.a | 2 |
8 | gr.b+c | 1 |
9 | dinac | 4 |
10 | telepsychiatric | 1 |
11 | administration-recommended | 3 |
12 | abuse-funded | 2 |
13 | administration-defined | 5 |
14 | interaction-determined | 1 |
15 | dependence-associated | 1 |
16 | administration-associated | 1 |
17 | p-mediated | 4 |
18 | use-related | 33 |
19 | consumption-related | 5 |
20 | use/protected | 1 |
21 | misuse-oriented | 1 |
22 | administrration-approved | 1 |
23 | administration-approved | 93 |
24 | administation-approved | 1 |
25 | apologized | 1 |
26 | carbabanzpyrid | 1 |
27 | consumption≥world | 1 |
28 | consumption/demand | 2 |
29 | usexaud | 1 |
30 | use/sud | 4 |
31 | abuse/dependence | 40 |
32 | breakage/slippage | 3 |
33 | challenge/de-challenge/re-challenge | 2 |
34 | offending.the | 1 |
35 | class-outcome | 1 |
36 | indomethacine | 5 |
37 | 2,2,6,6-tetramethylpiperidine | 4 |
38 | perlapine | 1 |
39 | 3-/4-flouroephedrine | 2 |
40 | maytensine | 1 |
41 | pentedrone | 1 |
42 | use.there | 2 |
43 | overdose | 361 |
44 | urges/use | 1 |
45 | abuse | 4,451 |
46 | dependence/abuse | 1 |
47 | misuse | 773 |
48 | use-as-coping | 2 |
49 | symptoms/suffering | 1 |
50 | p-expressing | 1 |
51 | abusing | 58 |
52 | opportunities-among | 1 |
53 | bosch | 3 |
54 | days-at-risk | 2 |
55 | offences.biological | 1 |
56 | dependence/harmful | 4 |
57 | addiction/alcoholism | 1 |
58 | use-driven | 1 |
59 | doxorubucin | 1 |
60 | released/min | 1 |
61 | p-saporin | 1 |
62 | prime/aggression | 1 |
63 | weight-classification | 1 |
64 | intoxication | 697 |
65 | admistration | 1 |
66 | uptake/retention | 1 |
67 | qinghao | 4 |
68 | treatments/placebo | 1 |
69 | vihar | 1 |
70 | hepatobiliar | 1 |
71 | liprimar | 1 |
72 | oxeglitazar | 3 |
73 | orientation/gender | 1 |
74 | abuser | 21 |
75 | classes-diuretics | 1 |
76 | pre-experiences | 1 |
77 | abuse/linjuries | 1 |
78 | overdoses | 81 |
79 | abuses | 34 |
80 | misallocations | 1 |
81 | reactions/interactions | 1 |
82 | drowns | 1 |
83 | stores/shops | 2 |
84 | age=4.4years | 1 |
85 | minders | 2 |
86 | dispensers/sellers | 1 |
87 | abusers | 290 |
88 | users/abusers | 1 |
89 | misusers | 16 |
90 | molesters | 5 |
91 | waivers | 9 |
92 | neediness | 1 |
93 | abstinents | 2 |
94 | reactions/events | 4 |
95 | abuse/neglect | 7 |
96 | use.genet | 1 |
97 | prolit | 4 |
98 | cross-tolerant | 1 |
99 | items/patient | 1 |
100 | approvement | 1 |
101 | maltreatment | 250 |
102 | detralex | 5 |
103 | abuse/day | 1 |
104 | torsadogenicity | 2 |
105 | rule/availability | 1 |
106 | behaviour/disability | 3 |
107 | attributability | 2 |
108 | cristallinity | 1 |
109 | soledum® | 1 |